Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

LDL Cholesterol

Low Density Lipoproteins (LDL) plays a key role in causing and influencing the progression of atherosclerosis and coronary sclerosis in particular. The LDLs are derived from VLDLs (Very Low Density Lipoproteins) rich in triglycerides by the action of various lipolytic enzymes and are synthesized in the liver. The elimination of LDL from plasma takes place mainly by liver parenchymal cells via specific LDL receptors.

Biorex Diagnostics manufactures LDL reagents designed for Hitachi 917, Olympus AU600/400/640, CA 180/270/400/2700 Furuno/Daytona system reagents.

Add to Quote

Description

Product Name Details CAT.No Size
LDL Cholesterol  Suitable for Hitachi 917 HIT0431G R1: 2 x 20ml R1: 1 x 14ml
LDL Cholesterol Direct Suitable for use on Olympus System AU600, AU400, AU640, AU2700 OLY0431H R1: 3 x 20ml R2: 2 x 10ml
Direct LDL Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents BXCF431A R1: 3 x 51ml R2: 3 x 20ml

 

 

Product Description

The Biorex Diagnostics LDL Cholesterol Assay is a high-quality in vitro diagnostic test designed for the quantitative determination of Low-Density Lipoprotein (LDL) cholesterol in human serum and plasma. LDL cholesterol, commonly referred to as “bad cholesterol,” is the primary lipoprotein responsible for transporting cholesterol from the liver to peripheral tissues. Elevated levels are strongly associated with atherosclerosis, cardiovascular disease, and other lipid-related disorders, making accurate measurement essential for risk assessment and disease management.

The use of validated assays provides an objective assessment of laboratory method performance and is an integral part of good laboratory practice. By incorporating the Biorex LDL Cholesterol Assay into routine workflows, laboratories can reliably monitor LDL levels, assess cardiovascular risk, and evaluate the effectiveness of lipid-lowering therapies. Regular measurement of LDL cholesterol is critical for identifying individuals at high risk of heart disease, supporting early intervention, and guiding clinical decision-making to improve long-term outcomes.

Manufactured under strict quality standards, the Biorex Diagnostics Assay delivers stable, reproducible, and clinically meaningful results. The assay’s enzymatic and photometric methods ensure high accuracy, sensitivity, and consistency, enabling laboratories to detect even subtle changes in LDL concentrations. It is fully compatible with automated analyzers, including Hitachi 917, Olympus AU600/400/640, and CA 180/270/400/2700 Furuno/Daytona systems, allowing seamless integration into laboratory workflows and supporting high-throughput testing without compromising reliability.

Key Features

  • Quantitative Measurement: Accurate determination in serum and plasma.
  • Clinical Relevance: Supports cardiovascular risk assessment and monitoring of hyperlipidemia.
  • High Accuracy and Reproducibility: Reliable results suitable for clinical and research applications.
  • Therapeutic Monitoring: Evaluates the effectiveness of lipid-lowering therapy.
  • Automated Analyzer Compatibility: Optimised for Hitachi, Olympus, and CA Furuno/Daytona systems.

Benefits

The Biorex LDL Cholesterol Assay provides laboratories with a dependable solution for assessing lipid profiles and cardiovascular risk. Its precision, reproducibility, and compatibility with automated systems make it an essential tool for clinical laboratories, hospital diagnostics, and cardiovascular research, supporting accurate interpretation, effective patient management, and improved clinical outcomes.

Contact Us for more information.

Additional information

Storage

2-8°C